Cargando…
Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Clinical Oncology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446533/ https://www.ncbi.nlm.nih.gov/pubmed/32913978 http://dx.doi.org/10.1200/PO.17.00049 |
| _version_ | 1783574153200140288 |
|---|---|
| author | Castellanos, Emily H. Feld, Emily Estrada, Monica V. Sanders, Melinda E. Massion, Pierre P. Johnson, Douglas B. Balko, Justin M. Horn, Leora |
| author_facet | Castellanos, Emily H. Feld, Emily Estrada, Monica V. Sanders, Melinda E. Massion, Pierre P. Johnson, Douglas B. Balko, Justin M. Horn, Leora |
| author_sort | Castellanos, Emily H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7446533 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | American Society of Clinical Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74465332020-09-09 Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy Castellanos, Emily H. Feld, Emily Estrada, Monica V. Sanders, Melinda E. Massion, Pierre P. Johnson, Douglas B. Balko, Justin M. Horn, Leora JCO Precis Oncol Case Reports American Society of Clinical Oncology 2017-08-15 /pmc/articles/PMC7446533/ /pubmed/32913978 http://dx.doi.org/10.1200/PO.17.00049 Text en © 2017 by American Society of Clinical Oncology http://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Case Reports Castellanos, Emily H. Feld, Emily Estrada, Monica V. Sanders, Melinda E. Massion, Pierre P. Johnson, Douglas B. Balko, Justin M. Horn, Leora Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy |
| title | Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy |
| title_full | Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy |
| title_fullStr | Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy |
| title_full_unstemmed | Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy |
| title_short | Clinical Response to Anti–Programmed Death 1 After Response and Subsequent Progression on Anti–Programmed Death Ligand 1 Therapy |
| title_sort | clinical response to anti–programmed death 1 after response and subsequent progression on anti–programmed death ligand 1 therapy |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446533/ https://www.ncbi.nlm.nih.gov/pubmed/32913978 http://dx.doi.org/10.1200/PO.17.00049 |
| work_keys_str_mv | AT castellanosemilyh clinicalresponsetoantiprogrammeddeath1afterresponseandsubsequentprogressiononantiprogrammeddeathligand1therapy AT feldemily clinicalresponsetoantiprogrammeddeath1afterresponseandsubsequentprogressiononantiprogrammeddeathligand1therapy AT estradamonicav clinicalresponsetoantiprogrammeddeath1afterresponseandsubsequentprogressiononantiprogrammeddeathligand1therapy AT sandersmelindae clinicalresponsetoantiprogrammeddeath1afterresponseandsubsequentprogressiononantiprogrammeddeathligand1therapy AT massionpierrep clinicalresponsetoantiprogrammeddeath1afterresponseandsubsequentprogressiononantiprogrammeddeathligand1therapy AT johnsondouglasb clinicalresponsetoantiprogrammeddeath1afterresponseandsubsequentprogressiononantiprogrammeddeathligand1therapy AT balkojustinm clinicalresponsetoantiprogrammeddeath1afterresponseandsubsequentprogressiononantiprogrammeddeathligand1therapy AT hornleora clinicalresponsetoantiprogrammeddeath1afterresponseandsubsequentprogressiononantiprogrammeddeathligand1therapy |